Victrex (OTCMKTS:VTXPF) Rating Lowered to Sell at Zacks Investment Research

Victrex (OTCMKTS:VTXPF) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Thursday, Zacks.com reports.

According to Zacks, “Victrex Plc engages in the manufacture and marketing of polymers. The company offers products under the Victrex, Aptiv, Vicote and Victrex Pipes brands. It operates through the Victrex Polymer Solutions and Invibio Biomaterial Solutions segments. Victrex Polymer Solutions segment focuses on the automotive, aerospace, electronics and energy markets. Invibio Biomaterial Solutions provides solutions for medical device manufacturers. Victrex Plc is headquartered in Thornton Cleveleys, United Kingdom. “

VTXPF opened at $30.15 on Thursday. The firm’s fifty day moving average is $31.90 and its two-hundred day moving average is $28.57. Victrex has a twelve month low of $22.41 and a twelve month high of $33.55.

Victrex Company Profile

Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company offers VICTREX PEEK polymer materials; and biomaterial solutions for use in spine, ortho, dental, trauma, knee, cardiovascular, and orthopedic applications. It also offers specialist solutions for medical device manufacturers.

Featured Article: Why Dividend Stocks May Be Right for You

Get a free copy of the Zacks research report on Victrex (VTXPF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.